Evaluation of Perioperative Myocardial Injury in Patients Undergoing Below-Knee Lower Extremity Surgery
Condition(s) studied
Investigational drug(s) / intervention(s)
high sensitive Troponin I: High sensitive Troponin I used to predict myocardial damage
Study summary
The aim of this observational study was to detect myocardial damage by monitoring high-sensitive troponin I levels in patients undergoing below-knee extremity surgery with peripheral nerve block.
The primary question it aims to answer is:
How effective are peroperative high-sensitive troponin I levels in predicting myocardial damage?
High-sensitive troponin I levels will be monitored intraoperatively and at 24 and 48 hours postoperatively.
Eligibility
Primary outcome measure(s)
- High sensitive Troponin I — 01.09.2025-10.01.2026
peroperative High sensitive Troponin I - High sensitive Troponin I — 01.09.2025-11.01.2026
postoperative 24th hour High sensitive Troponin I - High sensitive Troponin I — 01.09.2025-12.01.2026
postoperative 48th hour High sensitive Troponin I
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Ankara Bilkent City Hospital | Ankara | Turkey (Türkiye) | Recruiting |
More Ankara City Hospital Bilkent trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07241572 on ClinicalTrials.gov ↗ ← All trials in Turkey